Log in
Sign up
free
Home
Sectors
Earnings
IPOs
Splits
Example searches
AAPL 10-K FY2019
Visa 10-Q
shopify
renewables AND wind 8-K 6-K NOT TAC
cryptocurrency OR "blockchain technology" OR bitcoin 2018-2021
GXGX
Dashboard
GXGX
Financials
Financials
Data Charts
Data
Institutional Ownership Data
Ownership
Short Interest
Shorts
All Filings
Filings
8-K Filing
8-K
GXGX
Gx Acquisition
8-K
2021
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
8 Jan 21
Files
SEC
8-K
Current report
2.1
Merger Agreement and Plan of Reorganization, Dated As of January 8, 2021 by and Among GX Acquisition Corp., Alpha First Merger Sub, Inc., Alpha Second Merger Sub LLC and Celularity Inc
10.1
Form of Subscription Agreement
10.2
Form of Stockholder Support Agreement
10.3
Sponsor Support Agreement, Dated As of January 8, 2021 by and Among GX Acquisition Corp., Celularity Inc., GX Sponsor LLC and the Directors and Officers of GX Acquisition Corp. Set Forth Therein
99.1
Press Release, Dated January 8, 2021
99.2
Conference Call Script
99.3
Investor Presentation of GX, Dated As of January 8, 2021
Content Analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
GXGX 8-K Filings
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
4 Jan 21
Submission of Matters to a Vote of Security Holders
2 Dec 20
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
12 Jul 19
Other Events
Filing View
Default size
S
M
L
Default font
Times
Arial
Search this filing
Search
All
Tables only
Footnotes only
Pre-defined:
Material
ESG
Footnotes
Table of Contents
Get all this for free
Email alerts for new filings that match keywords or companies
Plot, compare & download financial data
10-K & 10-Q redlined comparisons
Advanced filing search & analysis
Sentiment analysis for financial filings
Favorites, search history, and more…
Sign up for free now
More benefits
Top
GXGX